Market Closed -
Toronto S.E.
04:00:00 2024-05-28 pm EDT
|
5-day change
|
1st Jan Change
|
5.05
CAD
|
-1.75%
|
|
-1.75%
|
-2.13%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
1,833
|
2,215
|
3,016
|
2,278
|
1,251
|
1,264
|
-
|
Enterprise Value (EV)
1 |
1,833
|
2,215
|
3,016
|
2,278
|
1,251
|
4,655
|
4,671
|
P/E ratio
|
-1,193
x
|
8.05
x
|
6.95
x
|
-
|
-
|
-
|
-
|
Yield
|
6.71%
|
6.35%
|
5.79%
|
-
|
-
|
7.13%
|
7.13%
|
Capitalization / Revenue
|
5.01
x
|
5.93
x
|
8.05
x
|
5.07
x
|
2.46
x
|
2.68
x
|
2.62
x
|
EV / Revenue
|
5.01
x
|
5.93
x
|
8.05
x
|
5.07
x
|
2.46
x
|
9.86
x
|
9.68
x
|
EV / EBITDA
|
7.16
x
|
8.27
x
|
11.3
x
|
7.3
x
|
2.96
x
|
14.2
x
|
13.9
x
|
EV / FCF
|
-
|
11.8
x
|
24.2
x
|
-
|
-
|
69.5
x
|
123
x
|
FCF Yield
|
-
|
8.51%
|
4.13%
|
-
|
-
|
1.44%
|
0.81%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
153,623
|
175,831
|
218,394
|
239,748
|
242,507
|
245,935
|
-
|
Reference price
2 |
11.93
|
12.60
|
13.81
|
9.500
|
5.160
|
5.050
|
5.050
|
Announcement Date
|
3/4/20
|
3/11/21
|
3/14/22
|
3/31/23
|
3/14/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
366
|
373.8
|
374.6
|
448.8
|
508
|
472.2
|
482.7
|
EBITDA
1 |
256.1
|
268
|
265.9
|
312
|
423.1
|
327
|
336.9
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-1.871
|
314.4
|
434.9
|
64.3
|
-347.7
|
16.46
|
116.6
|
Net margin
|
-0.51%
|
84.09%
|
116.09%
|
14.33%
|
-68.44%
|
3.49%
|
24.15%
|
EPS
|
-0.0100
|
1.565
|
1.988
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
188.5
|
124.5
|
-
|
-
|
67
|
38
|
FCF margin
|
-
|
50.43%
|
33.23%
|
-
|
-
|
14.19%
|
7.87%
|
FCF Conversion (EBITDA)
|
-
|
70.34%
|
46.82%
|
-
|
-
|
20.49%
|
11.28%
|
FCF Conversion (Net income)
|
-
|
59.97%
|
28.62%
|
-
|
-
|
407.1%
|
32.59%
|
Dividend per Share
2 |
0.8000
|
0.8000
|
0.8000
|
-
|
-
|
0.3600
|
0.3600
|
Announcement Date
|
3/4/20
|
3/11/21
|
3/14/22
|
3/31/23
|
3/14/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2023 Q2
|
2023 Q3
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
|
96.37
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
1 |
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.1600
|
0.0900
|
0.0900
|
0.0900
|
Announcement Date
|
3/14/22
|
5/12/22
|
8/12/22
|
11/15/22
|
8/11/23
|
11/8/23
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
3,391
|
3,407
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
10.37
x
|
10.11
x
|
Free Cash Flow
1 |
-
|
189
|
124
|
-
|
-
|
67
|
38
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/4/20
|
3/11/21
|
3/14/22
|
3/31/23
|
3/14/24
|
-
|
-
|
Last Close Price
5.05
CAD Average target price
5.667
CAD Spread / Average Target +12.21% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.13% | 927M | | +11.82% | 60.31B | | -4.49% | 13.44B | | +1.50% | 7.78B | | -9.17% | 5.92B | | +12.65% | 3.61B | | 0.00% | 3.34B | | -5.97% | 3.07B | | +4.07% | 3.03B | | +15.99% | 2.82B |
Healthcare REITs
|